A phase II clinical trial design for associated co-primary efficacy and toxicity outcomes with baseline covariates

Kristian Brock; Lucinda Billingham; Christina Yap; Gary Middleton

doi:10.1007/978-3-030-30611-3_13

A phase II clinical trial design for associated co-primary efficacy and toxicity outcomes with baseline covariates

Kristian Brock, Lucinda Billingham, Christina Yap, Gary Middleton

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Original language	English
Title of host publication	Bayesian Statistics and New Generations - BAYSM 2018, Selected Contributions
Editors	Raffaele Argiento, Daniele Durante, Sara Wade
Publisher	Springer
Pages	125-133
Number of pages	9
ISBN (Print)	9783030306106
DOIs	https://doi.org/10.1007/978-3-030-30611-3_13
Publication status	Published - 2019
Externally published	Yes
Event	4th Bayesian Young Statisticians Meeting, BAYSM 2018 - Warwick, United Kingdom Duration: Jul 2 2018 → Jul 3 2018

Publication series

Name	Springer Proceedings in Mathematics and Statistics
Volume	296
ISSN (Print)	2194-1009
ISSN (Electronic)	2194-1017

Conference

Conference	4th Bayesian Young Statisticians Meeting, BAYSM 2018
Country/Territory	United Kingdom
City	Warwick
Period	7/2/18 → 7/3/18

ASJC Scopus Subject Areas

General Mathematics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-030-30611-3_13

Cite this

Brock, K., Billingham, L., Yap, C., & Middleton, G. (2019). A phase II clinical trial design for associated co-primary efficacy and toxicity outcomes with baseline covariates. In R. Argiento, D. Durante, & S. Wade (Eds.), Bayesian Statistics and New Generations - BAYSM 2018, Selected Contributions (pp. 125-133). (Springer Proceedings in Mathematics and Statistics; Vol. 296). Springer. https://doi.org/10.1007/978-3-030-30611-3_13

A phase II clinical trial design for associated co-primary efficacy and toxicity outcomes with baseline covariates. / Brock, Kristian; Billingham, Lucinda; Yap, Christina et al.
Bayesian Statistics and New Generations - BAYSM 2018, Selected Contributions. ed. / Raffaele Argiento; Daniele Durante; Sara Wade. Springer, 2019. p. 125-133 (Springer Proceedings in Mathematics and Statistics; Vol. 296).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Brock, K, Billingham, L, Yap, C & Middleton, G 2019, A phase II clinical trial design for associated co-primary efficacy and toxicity outcomes with baseline covariates. in R Argiento, D Durante & S Wade (eds), Bayesian Statistics and New Generations - BAYSM 2018, Selected Contributions. Springer Proceedings in Mathematics and Statistics, vol. 296, Springer, pp. 125-133, 4th Bayesian Young Statisticians Meeting, BAYSM 2018, Warwick, United Kingdom, 7/2/18. https://doi.org/10.1007/978-3-030-30611-3_13

Brock K, Billingham L, Yap C, Middleton G. A phase II clinical trial design for associated co-primary efficacy and toxicity outcomes with baseline covariates. In Argiento R, Durante D, Wade S, editors, Bayesian Statistics and New Generations - BAYSM 2018, Selected Contributions. Springer. 2019. p. 125-133. (Springer Proceedings in Mathematics and Statistics). doi: 10.1007/978-3-030-30611-3_13

Brock, Kristian ; Billingham, Lucinda ; Yap, Christina et al. / A phase II clinical trial design for associated co-primary efficacy and toxicity outcomes with baseline covariates. Bayesian Statistics and New Generations - BAYSM 2018, Selected Contributions. editor / Raffaele Argiento ; Daniele Durante ; Sara Wade. Springer, 2019. pp. 125-133 (Springer Proceedings in Mathematics and Statistics).

@inproceedings{164fbdac36f940d7ae751ca4f09f70c0,

title = "A phase II clinical trial design for associated co-primary efficacy and toxicity outcomes with baseline covariates",

author = "Kristian Brock and Lucinda Billingham and Christina Yap and Gary Middleton",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Nature Switzerland AG.; 4th Bayesian Young Statisticians Meeting, BAYSM 2018 ; Conference date: 02-07-2018 Through 03-07-2018",

year = "2019",

doi = "10.1007/978-3-030-30611-3_13",

language = "English",

isbn = "9783030306106",

series = "Springer Proceedings in Mathematics and Statistics",

publisher = " Springer",

pages = "125--133",

editor = "Raffaele Argiento and Daniele Durante and Sara Wade",

booktitle = "Bayesian Statistics and New Generations - BAYSM 2018, Selected Contributions",

}

TY - GEN

T1 - A phase II clinical trial design for associated co-primary efficacy and toxicity outcomes with baseline covariates

AU - Brock, Kristian

AU - Billingham, Lucinda

AU - Yap, Christina

AU - Middleton, Gary

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85076640680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076640680&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-30611-3_13

DO - 10.1007/978-3-030-30611-3_13

M3 - Conference contribution

AN - SCOPUS:85076640680

SN - 9783030306106

T3 - Springer Proceedings in Mathematics and Statistics

SP - 125

EP - 133

BT - Bayesian Statistics and New Generations - BAYSM 2018, Selected Contributions

A2 - Argiento, Raffaele

A2 - Durante, Daniele

A2 - Wade, Sara

PB - Springer

T2 - 4th Bayesian Young Statisticians Meeting, BAYSM 2018

Y2 - 2 July 2018 through 3 July 2018

ER -

A phase II clinical trial design for associated co-primary efficacy and toxicity outcomes with baseline covariates

Publication series

Conference

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this